Despite its abuse potential, methylphenidate (MPH) is widely prescribed for treatment of attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine MPH self-administration in a rat model of ADHD. Experiment 1 examined the acquisition of MPH self-administration and assessed the MPH doseeffect curve in spontaneously hypertensive rats (SHR), an inbred rat model of ADHD, Wistar Kyotos (WKY), the progenitor strain for SHR, and Sprague-Dawley (SD), an outbred control strain. Experiment 2 replicated Experiment 1, but replaced MPH infusions with sucrose pellets. Initial acquisition of MPH self-administration was greater in SHR and SD than WKY. However, with extended training using an incrementing fixed ratio schedule SHR and WKY did not differ in responding for MPH using the training dose (0.3 mg/kg/infusion) or other unit doses, except that SHR showed greater responding than WKY at 0.1 mg/kg/ infusion. SHR also showed greater acquisition and maintenance of sucrose-reinforced responding compared with both WKY and SD. Greater initial acquisition of MPH self-administration in SHR than WKY may not be due to a strain-specific difference in sensitivity to the reinforcing effect of MPH.
Introduction
Attention-deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders among children, affecting 3-5% of the school age population (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; American Psychiatric Association, 2000) . ADHD is characterized by a heterogeneous combination of behavioral symptoms (Sagvolden et al., 2005) , including inattentiveness, impulsiveness, and/or hyperactivity that usually manifests by 7 years of age (Sagvolden and Sergeant, 1998) . Although the cause is not fully understood, research suggests that ADHD results from hypofunctioning dopaminergic systems (Sagvolden and Sergeant, 1998; Volkow et al., 2009) . Interestingly, both genetic and environmental etiologies have been proposed to explain the dopamine dysfunction that gives rise to ADHD (Volkow et al., 2009) . The most common treatment for ADHD involves prescribing of stimulants, including methylphenidate (MPH; Challman and Lipsky, 2000; Volkow and Swanson, 2003; Wilens et al., 2003) . The number of prescriptions for MPH and other stimulants increased from less than 2 million in 1991 to over 10 million in 2001 (Volkow and Swanson, 2003) . MPH alone is being used to treat 5-15% of children and adolescents in the USA. (Barbaresi et al., 2002) . Although clinical trials show that MPH effectively reduces the problematic behavioral symptoms of ADHD, there has been increasing concern about the abuse potential of MPH with long-term use.
MPH has been found to be a reinforcer in humans with ADHD, and humans with and without ADHD have reported 'liking' the effects of MPH and would take it again ). Similar to cocaine and methamphetamine, MPH increases extracellular dopamine in brain regions associated with reward, including the nucleus accumbens (Di Chiara and Imperato, 1988) . One study found that children diagnosed with ADHD preferred MPH over a placebo in a double-blind choice procedure (Fredericks and Kollins, 2005) . Further, calls to the National Poison Data System regarding abuse of MPH or amphetamine originally prescribed for ADHD increased 76% in adolescents between the years of 1998 and 2005, whereas the total number of calls to the National Poison Data System did not increase during this time period. Some of the cases that generated these calls resulted in life-threatening situations or even death as a result of MPH abuse (Setlik et al., 2009) . Owing to an increase in the number of MPH prescriptions and documented misuse, it is clear that there is a legitimate cause for concern about the abuse potential of MPH. In addition, adults who show all the characteristics of ADHD are more likely to have used cigarettes and marijuana, and are more likely to have tried a variety of drugs compared with adults without ADHD . With respect to ADHD medications in particular (MPH and amphetamine), research has found that individuals with and without ADHD abuse these medications (Wilens et al., 2008 for a review) . Investigations of the risk of future drug abuse because of a history of using stimulants to treat ADHD has yielded mixed results, with some studies showing no effect, some showing increased vulnerability, and some showing a protective effect (Lambert and Hartsough, 1998; Wilens et al., 2003; Faraone and Upadhyaya, 2007; Kollins, 2007; Biederman et al., 2008) .
One way to help understand the effects of MPH in individuals with ADHD is to use an animal model under controlled conditions. Although many preclinical models have been proposed (Adriani et al., 2003; Davids et al., 2003) , the most widely used animal model of ADHD is the spontaneously hypertensive rat (SHR; Sagvolden et al., 2005; Russell, 2007; Pardey et al., 2009) . SHR is an inbred strain that was derived from Wistar Kyoto (WKY) rats, and was originally bred for cardiovascular research. SHR exhibit the main characteristics of clinically diagnosed ADHD, including hyperactivity, impulsiveness, and inattention compared with their normotensive WKY control strain (Sagvolden and Sergeant, 1998; Sagvolden, 2000; Russell, 2002) . More specifically, compared with WKY controls, SHR are hyperactive (Amini et al., 2004; Sukhanov et al., 2004) and show greater impulsivity on a variety of tasks, including delay discounting, differential reinforcement of low rates, and a fixed consecutive number task (Evenden and Meyerson, 1999; Fox et al., 2008; Sanabria and Killeen, 2008; Pardey et al., 2009) . Although SHR are presumed to be a valid animal model of ADHD, their use in behavioral research is not without criticism. Some reports have shown that SHR do not display ADHD characteristics consistently, and that the hyperactivity or impulsivity-decreasing effects of MPH only occur for WKY and Wistar rats (Van den Bergh et al., 2006) . Other reports have shown that hyperactivity in SHR is artificially inflated when compared with WKY, because WKY are hypoactive (Alsop, 2007) . Despite these criticisms, the SHR strain continues to be the most commonly used animal model of ADHD (Sagvolden et al., 2005) .
Although there are currently no reports examining MPH reinforcement among inbred rat strains, evidence indicates that SHR respond differently to the psychostimulant effects of MPH compared with WKY. In these studies, outbred Sprague-Dawley (SD) rats are often included as a comparison because they model 'normal' variability in behavior (Pardey et al., 2009) . With locomotor activity, MPH produces hyperactivity in SHR, WKY, and SD (Yang et al., 2003; ; however, the MPH-induced hyperactivity in SHR is longer in duration and amplitude than SD (Amini et al., 2004) . In contrast, across repeated administration, MPH (2.5 mg/kg) produces sensitization in WKY and SD, but not SHR (Yang et al., 2003) . Thus, SHR may be more sensitive to the initial psychostimulant effect of acute MPH, but not repeated MPH. To the extent that the stimulant and reinforcing effects of MPH share common mechanisms, these results suggest that SHR may be more sensitive to the initial reinforcing effect of MPH, but not the long-term reinforcing effect.
Multiple studies show evidence for MPH serving as an intravenous reinforcer in outbred SD rats. One study found that MPH was as reinforcing as cocaine (Collins et al., 1984) , and another study found that rats selfadministering amphetamine (0.06 mg/kg/infusion) continued to lever press at the same rate when the drug was switched to MPH (0.2 or 0.4 mg/kg/infusion; Nielsen et al., 1984) . More recent experiments have found that rats will self-administer a variety of doses of MPH on fixed ratio (FR) and progressive ratio schedules, will lever press more for a variety of MPH doses compared with saline, and will lever press more on an active (MPH delivery) lever than an inactive (no drug delivery) lever (Botly et al., 2008; Marusich and Bardo, 2009; Marusich et al., 2010) . In addition, noncontingent MPH does not maintain lever pressing, and MPH self-administration is subject to escalation of self-administration when rats are given daily long access to the drug (Marusich et al., 2010) . Both adult (Botly et al., 2008; Marusich and Bardo, 2009; Marusich et al., 2010) and adolescent (Burton et al., 2010) outbred rats have been shown to lever press for MPH; however, no published studies have examined MPH self-administration in inbred strains. Thus, the purpose of these experiments was to examine MPH selfadministration in SHR, WKY, and SD. These strains were also compared for their responding using a nondrug (sucrose pellet) reinforcer under similar conditions.
Methods

Subjects
Experiment 1 used 12 male SHR, 12 male WKY, and 12 male SD rats, all approximately 70 days old (Harlan Industries, Indianapolis, Indiana, USA). Experiment 2 used 12 male SD (Harlan Industries), 12 male SHR (Harlan Industries), and 12 male WKY (Charles River Laboratories Inc., Indianapolis, Indiana, USA) rats, all approximately 70 days old. WKY were ordered from a vendor different from Experiment 1 because of unavailability from Harlan. Rats were experimentally naive and drug naive at the beginning of the experiment. They were housed in individual, hanging plastic home cages in a colony on a 16/8 h light/dark cycle (lights on at 06 : 00 h). They had free access to water in the home cage, and were restricted to a constant amount of daily food based on the average weight of rats of each strain at 70 days of age (Table 1 ). SD were fed 20 g of food daily, SHR 15 g, and WKY were fed 14 g of food daily. Food was delivered immediately after the session for all rats. Experimental protocols were approved by the Institutional Animal Care and Use Committee at the University of Kentucky, and followed the principles of laboratory animal care.
Apparatus
Experimental sessions were conducted in standard operant conditioning chambers for rats (28 Â 24 Â 25 cm; ENV-001; MED Associates, St Albans, Vermont, USA) housed inside sound-attenuating chambers (ENV-018M; MED Associates). Sucrose pellets (F0042 sugar-based dustless precision pellets, 45 mg, Bio-Serv, Frenchtown, New Jersey, USA) were dispensed individually from a pellet dispenser (ENV-203M-45; Med Associates) into a recessed food receptacle (5 Â 5 Â 3 cm) located 2 cm above the floor and centered on the front wall. Retractable levers (4.5 cm) were located 6 cm above the floor on each side of the food receptacle on the front wall, and white stimulus lights (28 V; 3 cm in diameter) were located 3 cm above each lever. Side walls were made of Plexiglas, the front and back walls were aluminum, and floors were made of metal rods. A fan located inside the sound-attenuating chamber produced noise to mask extraneous sounds. Experimental events were arranged and recorded by MED-PC software (Med Associates) on a computer in the experimental room. The same chambers were used for all the three strains. Experiment 1 Self-administration surgical procedure Before any experimental manipulations, rats were surgically implanted with a chronic indwelling jugular catheter (0.2 mm in diameter). Before the surgical procedure, rats were anesthetized with 100 mg/kg ketamine and 5 mg/kg diazepam (intraperitoneal). One end of the catheter was inserted into the jugular vein, and the other end was attached to a metal cannula that exited the skin. The cannula was secured in a head mount adhered to the skull with dental acrylic and metal jeweler screws. Catheter patency was maintained by 0.2 ml infusions of a mixture containing 20 ml saline, 0.6 ml heparin, and 0.2 ml gentamicin administered daily after experimental sessions.
Before daily experimental sessions, the cannula was attached to tubing within a flexible, spring covered leash (PHM-120; MED Associates) that was connected to a swivel (PHM-115; MED Associates) outside the operant chamber. This tubing exited the operant chamber and was connected to an infusion pump (PHM-100; MED Associates) located adjacent to the sound-attenuating chamber.
Acquisition of MPH self-administration
Rats were trained to press a lever for 0.3 mg/kg/infusion MPH through the method of autoshaping (Carroll and Lac, 1993) . This particular dose of MPH was selected because it has been used earlier to establish lever pressing for MPH in rats, and produces stable response rates (Marusich and Bardo, 2009; Marusich et al., 2010) . Rats were exposed to autoshaping sessions for seven consecutive daily sessions in which the active (drug) lever was extended into the chamber on a random time of 60-s. Following 15 s of lever extension or a lever press, the lever retracted and an infusion (0.1 ml; 0.3 mg/kg/ infusion) of MPH was delivered over 5.9 s. The infusion was paired with a 20-s time-out, signaled by the illumination of both the stimulus lights, during which lever pressing had no programmed consequence. The inactive lever (no drug) was present at all times, except during time-outs. The side of the operant chamber corresponding to the active lever was counter balanced across rats. Rats earned or were noncontingently delivered 10 infusions of MPH during the first 15 min of the session. Rats then remained in the chamber for an additional 45 min with only the inactive lever present and no drug infusions available. Autoshaping sessions were followed by a subsequent daily session in which MPH (0.3 mg/kg/infusion) was available on a FR1 for 60 min. Autoshaping and FR1 sessions were separated by a 30-90 min interval. Rats were exposed to daily autoshaping and FR1 sessions for seven consecutive days.
Following this, autoshaping sessions were terminated and rats were continued on access to contingent MPH (0.3 mg/kg/infusion) on a FR1 schedule for three consecutive days, followed by 3 days on FR2, 3 days on FR3, 3 days on FR4, and 7 days on FR5. This progression through FR1-FR5 was chosen because it was earlier used to establish acquisition of MPH self-administration in rats (Marusich and Bardo, 2009 ). Throughout the experiment, doses were administered on mg per kg of Weight gain from the beginning to the end of the experiments was due to both aging and the change from food restriction to free feeding (see Methods). SD, Sprague-Dawley; SHR, spontaneously hypertensive rats; WKY, Wistar Kyotos.
body weight basis (within a 20 g body weight range), with drug concentrations adjusted to keep the infusion volume constant. Therefore, despite the weight differences between strains, rats received the same unit dose at a constant rate and volume. All FR sessions were 60 min in duration, and there was no limit to the number of MPH infusions that could be earned during the session beyond the 20-s time-outs imposed after each infusion. This phase of the experiment was conducted over a course of 26 consecutive days.
MPH dose-effect determination
During the next phase of the experiment, rats were given access to different unit doses of MPH for self-administration on a FR5 schedule of reinforcement. Rats were tested with 0.056, 0.1, 0.56, and 1.0 mg/kg/infusion MPH in either ascending or descending order, with half of the rats in each strain tested in each order. These specific doses were selected because they produce differential response rates in SD (Marusich and Bardo, 2009; Marusich et al., 2010) , and thus would be sensitive to potential shifts in the dose-effect curves among strains based on differences in MPH reinforcement. All doses were administered at a volume of 0.1 ml/infusion. Rats were exposed to each dose for three consecutive sessions. Rats were then exposed to saline self-administration for seven consecutive sessions. This phase of the experiment was conducted for 19 consecutive days.
MPH self-administration during free feeding
After the seventh extinction session of saline selfadministration, rats were no longer food restricted, but were allowed free access to food in the home cage. Rats were then retested with the original training dose of MPH (0.3 mg/kg/infusion) on a FR5 schedule of reinforcement for seven consecutive daily sessions. This manipulation was conducted to examine potential strain-dependent effects on MPH self-administration during free feeding. Previous research has been conducted with rats on food restriction (Botly et al., 2008; Marusich and Bardo, 2009; Marusich et al., 2010) , and if rats continued to lever press for MPH while free feeding, this would be further evidence that MPH is a robust reinforcer for rats (c.f. De Wit and Stewart, 1981; Carroll and Lac, 1993) .
If a catheter malfunctioned, the rat was removed from the experiment and all data were excluded from that phase of the experiment. The three phases were defined as acquisition (autoshaping, FR5), dose-effect determination (including saline), and self-administration during free feeding. Nine SHR, nine SD, and eight WKY completed the acquisition phase; six SHR, seven SD, and eight WKY completed the dose-effect determination phase; and five SHR, six SD, and seven WKY completed self-administration during the free feeding phase.
Experiment 2 Acquisition of lever pressing for sucrose
In this phase, rats were exposed to identical autoshaping procedures as were used for the acquisition of MPH self-administration phase in Experiment 1, except that the rats did not undergo surgery and one sucrose pellet (45 mg, Bio-Serv) was delivered in place of the drug infusion. The programs used and lever press training were otherwise identical to that used in Experiment 1. Rats were exposed to autoshaping sessions for seven consecutive days, followed by training on FR1, FR2, FR3, FR4, and FR5.
Lever pressing for sucrose during free feeding
After the completion of lever pressing for sucrose on a FR5 schedule of reinforcement for seven sessions, rats were given free access to food in the home cage. They were then exposed to the FR5 schedule for another seven consecutive sessions.
Lever press extinction
In this phase, lever pressing no longer produced sucrose pellets, but the completion of five responses was still paired with stimulus light onset and a time out. The purpose of this phase was to approximate the saline substitution used in Experiment 1. Therefore, lever pressing in this phase still produced the stimulus light, but it did not provide any pellet reinforcement, similar to saline substitution in Experiment 1. Rats were exposed to this phase for seven consecutive sessions.
Drug MPH HCl (Mallinckrodt, St Louis, Missouri) was prepared in sterile 0.9% NaCl (saline).
Data analysis Experiment 1
Mixed-factor analyses of variance (ANOVAs) were used to compare the number of active and inactive lever presses across the 7 days of acquisition for all the three strains, and during exposure to different FR values. Another mixed-factor ANOVA was used to compare lever pressing during food restriction and free feeding across strains lever pressing on a FR5. During dose-effect determination, only the final two sessions of exposure to each dose were used in graphical and statistical analyses. An additional mixed factor ANOVA was used to compare the number of active lever presses for each dose of MPH (including saline) from the dose-effect determination phase across the three strains. Bonferroni adjusted pairwise comparisons were used as post-hoc tests to compare strains for all ANOVAs that produced significant results and to compare across strains at individual doses from the dose-effect. All tests were considered significant at P value less than 0.05, except when a levels were adjusted for Bonferroni comparisons where appropriate.
Experiment 2
Mixed-factor ANOVAs were used to compare the number of active and inactive lever presses across the 7 days of acquisition for all three strains, and during exposure to different FR values. Additional mixed-factor ANOVAs were used to compare lever pressing during food restriction and free feeding phases across strains, and to compare lever pressing during free feeding on a FR5 and during free feeding on extinction. Bonferroniadjusted pairwise comparisons were used as post-hoc tests to compare strains for all ANOVAs that produced significant results. All tests were considered significant at P value less than 0.05, except when a levels were adjusted for Bonferroni comparisons where appropriate.
Results
Experiment 1 Figure 1a shows the number of active lever presses for each strain during the first seven sessions of FR1 acquisition. Inactive lever presses did not differ between the three strains and are therefore not presented (inactive lever pressing remained low across sessions, averaging less than 10 presses per session). The number of active lever presses was significantly different across acquisition sessions [F(6,138) = 8.74, P < 0.05], with rats in all strains increasing the number of active lever presses across sessions. There also was a significant main effect of strain for active lever presses during acquisition [F(2,23) = 15.31, P < 0.05], indicating that the strains differed in total number of lever presses collapsed across sessions. Subsequent post-hoc analyses showed that SHR and SD lever pressed significantly more than WKY [SHR vs. WKY: t(117) = 5.93, P < 0.05; SD vs. WKY: t (117) = 7.97, P < 0.05]. However, there was no interaction between session and strain, indicating that the pattern of responding across acquisition was not significantly different among strains. Figure 1b shows active lever presses for each strain across different FR values when rats self-administered 0.3 mg/kg/infusion MPH. Again, there were no significant differences among strains in the number of inactive lever presses, and therefore inactive lever presses are not presented. Active lever pressing increased with the higher FR requirements owing to the increase in workload necessary to obtain MPH. There were significant main effects of FR value [F(4,92) = 173.52, P < 0.05] and strain [F(2,23) = 6.01, P < 0.05], but no significant interaction. Subsequent post-hoc analyses indicated that each strain lever pressed more as the FR requirement was increased [SHR: F(4,32) = 121.89, P < 0.05; WKY: F(4,32) = 84.53, P < 0.05; SD: F(4,32) = 35.58, P < 0.05]. Collapsed across incremental FR values, SHR and WKY did not differ significantly; however, SD lever pressed more overall than WKY during incremental FR training [t(253) = 4.77, P < 0.05]. Figure 2 shows the number of active lever presses for each strain while responding on FR5 for 0.3 mg/kg/infusion MPH during food restriction and free feeding phases.
There were no significant differences in lever pressing based on feeding regimen, and there was no interaction between feeding regimen and strain. There was a significant main effect of strain [F(2,16) = 3.81, P < 0.05], with SD tending to show more lever pressing than SHR and WKY. However, subsequent post-hoc analyses did not reveal any significant differences among strains. Figure 3a shows the number of active lever presses for each strain during the dose-effect determination. ANOVA showed significant main effects of dose [F(5,90) = 80.11, P < 0.05] and strain [F(2,18) = 10.64, P < 0.05], as well as a significant dose Â strain interaction The relatively small magnitude of effect observed at 1.0 mg/kg/infusion, while not obvious in the graph (Fig. 3a) , was statistically significant because of the low variance obtained across strains at this unit dose. Figure 4a shows the number of active lever presses for each strain during the first seven sessions of acquisition. Inactive lever presses did not differ among the three strains and are therefore not presented (inactive lever pressing remained low across sessions, averaging less than 10 presses per session). The number of active lever presses was significantly different across sessions of FR1 acquisition [F(6,198) = 47.07, P < 0.05], with rats in all strains increasing the number of lever presses across sessions, although the increase was primarily from the first to second session. There also was a significant main effect of strain for active lever presses during acquisition [F(2,33) = 22.77, P < 0.05], with SHR lever pressing significantly more than WKY [t(166) = 8.86, P < 0.05] and SD [t(166) = 8.12, P < 0.05]. However, there was no significant interaction between session and strain, indicating that the pattern of responding across acquisition was not significantly different among strains. Number of active lever presses for the mean of each strain plotted as a function of session during food restriction compared with free feeding conditions. SD, Sprague-Dawley; SHR, spontaneously hypertensive rats; WKY, Wistar Kyotos. Figure 4b shows active lever presses for each strain across incremental FR values. Again, there were no significant differences among strains in the number of inactive lever presses and therefore inactive lever presses are not presented. Figure 5 shows the number of active lever presses for each strain while responding on FR5 during food restriction and free feeding, and then during lever press extinction. ANOVA comparing average lever pressing during food restriction and free feeding revealed significant main effects of feeding regimen As shown in Fig. 5 , ANOVA comparing sucrosereinforced lever pressing during free feeding to lever pressing during extinction showed significant main effects of contingency [F(1,33) = 235.13, P < 0.5] and strain [F(2,33) = 54.23, P < 0.05], as well as a significant strain Â contingency interaction [F(2,33) = 39.89, P < 0.05]. All three strains showed a significant decrease in the number of responses when switched from contingent food delivery to extinction [SHR: t(166) = 19.82, P < 0.05; WKY: t(166) = 12.16, P < 0.05; SD: t(166) = 10.32, P < 0.05]. In addition, while SHR lever pressed significantly more than the other two strains during both the free feed [SHR vs. WKY: t(166) = 17.14, P < 0.05; SHR vs. SD: t(166) = 15.53, P < 0.05] and extinction phases [SHR vs. WKY: t(166) = 7.49, P < 0.05; SHR vs. SD: t(166) = 7.29, P < 0.05], the difference was reduced in the extinction phase.
Discussion
Experiment 1 found that SHR, WKY, and SD acquired MPH self-administration, and this was achieved in each strain without previous training to lever press for food or for another drug. Switching from food restriction to free feeding had no significant effect on MPH self-administration, suggesting that MPH is a relatively robust reinforcer for all three strains. This finding contrasts with earlier research showing that acquisition and maintenance of cocaine self-administration is decreased when rats are free fed (De Wit and Stewart, 1981; Carroll and Lac, 1993 ). More importantly, as an ADHD model, SHR acquired MPH self-administration more rapidly early in training compared with the genetic progenitor control WKY, suggesting that SHR may either have a greater sensitivity to MPH reinforcement or an enhanced ability to learn the operant response. In contrast, with extended training and increasing FR requirements, there was no difference in MPH self-administration between SHR and WKY, indicating that any potential difference in MPH reinforcement was restricted to the early training phase. An analysis of the data from the incremental FR phase expressed as a percent change from baseline, with baseline defined as the last day of autoshaping, showed that WKY gradually increased responding by approximately 350% over the course of the incremental FR phase, whereas SHR and SD showed an initial high rate of responding that showed little increase over the incremental FR phase (data not shown). Altogether, these results suggest that SHR may learn faster than WKY. While the exact reason behind these strain dependent differences in acquisition of responding was not identified in the present experiment, these differences were not likely attributable to differences in body weight. Although the relative differences in weight across strains remained constant throughout the experiment (SD were B40 g heavier than SHR; SHR were B40 g heavier than WKY; Table 1) , differences in MPH self-administration did not remain constant. Thus, the differences in weight cannot, by themselves, account for the differences in acquisition of MPH self-administration.
SHR neither differed from SD controls in lever pressing at any point in training, nor did they differ in MPH intake at any unit dose of MPH. In addition, SHR did not differ from WKY during the incremental FR phase or when the unit dose of MPH was varied between 0.056 and 1.0 mg/kg/infusion, except at one dose (0.1 mg/kg/infusion). Thus, the enhanced MPH self-administration in SHR compared with WKY early in training does not seem to survive with extended training. These results are generally consistent with earlier results for locomotor activity showing that while SHR may show greater hyperactivity than WKY and SD after acute MPH (Amini et al., 2004) , this difference dissipates with repeated MPH (2.5 mg/kg; Yang et al., 2003) . Further, these results are consistent with earlier results showing that while SHR initially acquire amphetamine self-administration more rapidly than WKY, these strains display similar rates of amphetamine self-administration with extended training across incremental FR sessions and multiple unit doses (Meyer et al., 2010) .
An interesting finding of the present study was that SHR did not differ significantly from SD in MPH selfadministration, whereas SHR did differ from WKY in some aspects of MPH self-administration. The two control strains, SD and WKY, differed from each other in many aspects of MPH self-administration. Earlier research suggests that the differences between SHR and WKY may arise because WKY are hypoactive (Alsop, 2007) . While locomotor activity was not measured in the present study, the hypoactivity of WKY could have led to lower rates of MPH self-administration. SD rats are not used as a comparison strain for SHR as commonly as WKY, so it is difficult to determine whether SD and SHR would show similarities in other behavioral tasks, and whether the two strains would show similar effects of MPH on behavioral tasks. Results of this experiment also call into question the appropriate control strain for SHR. Future experiments should further compare SD with SHR in both in-vivo and in-vitro research to aid in answering these questions.
To the extent that the SHR model translates to humans with ADHD (Sagvolden et al., 2005; Russell, 2007; Pardey et al., 2009) , these preclinical results suggest that the presence of ADHD may confer greater risk for stimulant abuse compared with non-ADHD populations based on the faster acquisition of MPH self-administration in the SHR strain. Given that humans have a limited number of exposures to stimulants, the rate at which they acquire drug use is an important factor in whether or not future drug abuse will develop. Therefore, if people with ADHD are more likely to initiate stimulant use faster after initial exposure, they may also be more likely to develop an abuse pattern.
Experiment 2 found that, similar to MPH self-administration, SHR, WKY, and SD acquired sucrose-reinforced responding, and that each strain showed a similar pattern of acquisition. Switching from food restriction to free feeding decreased sucrose-reinforced responding, indicating that altering hunger motivation affected performance in all strains. However, this effect was different for each strain as indicated by the interaction in effects of feeding regimen and strain. This manipulation produced a larger change for SHR and WKY strains compared with SD. More important, SHR acquired sucrose-reinforced responding more rapidly during initial exposure compared with WKY and SD, suggesting that SHR may be more sensitive to sucrose reinforcement or may have an enhanced ability to learn the operant response. In contrast to the MPH self-administration results, however, the greater lever pressing for sucrose in SHR rats was maintained across all sessions, including the incremental FR and free feed phases. An interesting manipulation for future research would be to establish responding for sucrose in these strains, and then switch the reinforcer to MPH. Regardless, the present results indicate that the enhanced MPH self-administration noted in SHR during early training is not specific to MPH, but rather reflects a more general enhancement in lever press performance.
Earlier research has found that SHR acquire a task faster when the task involves varying their behavior, whereas WKY acquire a task faster when the task involves repeating their behavior (Mook and Neuringer, 1994; Mook et al., 1993) . Learning to self-administer drug requires an initial variation in behavior until the correct behavior is emitted, and then it requires repeating that behavior. Therefore, those earlier findings could account for why SHR initially acquired MPH self-administration more quickly than WKY while the two strains did not differ in lever pressing during the later phases of the experiment.
Regardless of any strain differences, these results corroborate earlier research showing that intravenous MPH is a robust reinforcer in outbred rats (Collins et al., 1984; Nielsen et al., 1984; Botly et al., 2008; Marusich and Bardo, 2009; Burton et al., 2010; Marusich et al., 2010) .
The present experiments add to this literature by showing that rats will self-administer MPH under free feeding conditions. In addition, this is the first demonstration that inbred rat strains (SHR and WKY) will selfadminister MPH in patterns similar to outbred rats. Future research may examine whether this pattern of drug self-administration in young adulthood is altered by early life (adolescent) exposure to MPH using an ADHD rat model.
While rats in the present experiment self-administered MPH for over 30 consecutive days, there was little evidence of tolerance or sensitization. A common method to show the development of tolerance or sensitization is to redetermine the dose-effect curve after extended drug exposure, or to examine changes in responding after prolonged exposure to a single dose (Hardman et al., 1996; Rang et al., 2003) . In Experiment 1, rats were trained on one dose (0.3 mg/kg/infusion MPH) under a FR5 schedule for seven consecutive sessions (Fig. 1b) , but showed no significant change in lever pressing, which suggests that tolerance did not develop. Similarly, none of the earlier experiments examining MPH self-administration in rats provide any evidence for the development of tolerance or sensitization (Botly et al., 2008; Marusich and Bardo, 2009; Burton et al., 2010; Marusich et al., 2010) . Nonetheless, we cannot rule out the possibility that SHR are more sensitive than WKY to MPH reinforcement early in training, but that tolerance develops to this effect, thus negating any potential strain-dependent difference.
While the present study is the first to show selfadministration of MPH in an animal model of ADHD, limitations remain. One limitation is that only the descending limb of the dose-effect curve was characterized. The doses of MPH were chosen based on earlier study examining MPH self-administration in SD (Marusich and Bardo, 2009; Marusich et al., 2010) . Earlier research found that unit doses of 0.03 and 0.056 mg/kg/infusion engendered a response rate that was on the ascending portion of the FR or progressive ratio dose-effect curve, and only slightly higher than responding for saline (Marusich and Bardo, 2009; Marusich et al., 2010) . There were several procedural differences among studies that do not allow any firm conclusions about why the lowest dose in this study (0.056 mg/kg/infusion) engendered robust responding compared with saline. Future research should characterize the ascending limb of the dose-effect curve of MPH self-administration in SHR and WKY. Another limitation of the present experiment was that all rats were trained to lever press for MPH using the same unit dose of MPH (0.3 mg/kg/infusion). Earlier research found that the training dose can affect the acquisition of drug selfadministration (Schenk and Partridge, 2000) , and thus it is possible that long-lasting differences among strains may have been observed if rats were trained to lever press using a different training dose of MPH.
Although the current study did not examine directly any neural mechanisms, other research has found that SHR have reduced electrically evoked and MPH-evoked dopamine release in slices from prefrontal cortex, nucleus accumbens, and caudate-putamen compared with WKY (Russell et al., 1995; Russell et al., 1998) . Extended exposure to MPH does not ameliorate the dopamine hypofunctioning in SHR (Russell et al., 2000) . Additional research using in-vivo microdialysis found differences in extracellular dopamine levels between SHR and WKY in various brain regions (Carboni et al., 2003; Fujita et al., 2003) , as well as greater MPH-evoked dopamine release in nucleus accumbens from SHR compared with WKY when MPH was administered acutely (Carboni et al., 2003) . The enhanced release of accumbal dopamine after acute MPH may play a role in the enhanced acquisition of MPH self-administration in SHR. Therefore, early exposure to MPH may be more reinforcing for SHR compared with WKY.
Finally, in addition to differences in dopamine function, we cannot rule out the possibility that greater bioavailability of MPH in SHR may have also played a role in the behavioral differences obtained in MPH self-administration. Unfortunately, there is no published information on the pharmacokinetics of MPH in SHR and WKY. With regard to the sucrose-reinforced responding experiment, however, SHR have an increased insulin response (Buchanan et al., 1992) that has been linked to the onset of obesity in this inbred strain (De Artiñano, and Castro, 2009 ). Therefore, SHR may lever press more for sucrose than WKY because of greater absorption of blood sugars into depot store. Additional study is needed to determine what pharmacodynamic and/or pharmacokinetic differences play a role in explaining the enhanced initial acquisition of MPH self-administration in SHR.
